Article Correctness Is Author's Responsibility: NDA Submitted for Valtoco Nasal Spray to Treat Acute Repetitive Seizures

The article below may contain offensive and/or incorrect content.

The Company states that the NDA is supported by robust clinical trial data, including patients studies where more than 1600 seizures were treated with Valtoco nasal spray.